Related Experiment Video
Updated: Jul 30, 2025

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Skin basal cell carcinomas assemble a pro-tumorigenic spatially organized and self-propagating Trem2+ myeloid niche
Daniel Haensel1,2, Bence Daniel3,4, Sadhana Gaddam1,2
1Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.
Abstract:
Cancer immunotherapies have revolutionized treatment but have shown limited success as single-agent therapies highlighting the need to understand the origin, assembly, and dynamics of heterogeneous tumor immune niches. Here, we use single-cell and imaging-based spatial analysis to elucidate three microenvironmental neighborhoods surrounding the heterogeneous basal cell carcinoma tumor epithelia. Within the highly proliferative neighborhood, we find that TREM2+ skin cancer-associated macrophages (SCAMs) support the proliferation of a distinct tumor epithelial population through an immunosuppression-independent manner via oncostatin-M/JAK-STAT3 signaling. SCAMs represent a unique tumor-specific TREM2+ population defined by VCAM1 surface expression that is not found in normal homeostatic skin or during wound healing. Furthermore, SCAMs actively proliferate and self-propagate through multiple serial tumor passages, indicating long-term potential. The tumor rapidly drives SCAM differentiation, with intratumoral injections sufficient to instruct naive bone marrow-derived monocytes to polarize within days. This work provides mechanistic insights into direct tumor-immune niche dynamics independent of immunosuppression, providing the basis for potential combination tumor therapies.
Insights
Skin cancer-associated macrophages (SCAMs) promote tumor cell proliferation via oncostatin-M/JAK-STAT3 signaling, independent of immunosuppression. These unique macrophages are tumor-specific and self-propagate, offering potential for new combination therapies.
Area of Science:
- Cancer Biology
- Immunology
- Dermatology
Background:
- Cancer immunotherapies have advanced treatment but often require combination strategies.
- Understanding tumor immune niches is crucial for improving therapeutic efficacy.
- Heterogeneity within tumor microenvironments influences treatment outcomes.
Purpose of the Study:
- To elucidate the origin, assembly, and dynamics of tumor immune niches in basal cell carcinoma.
- To identify specific immune cell populations and their interactions within the tumor microenvironment.
- To uncover mechanisms of tumor cell proliferation driven by immune cells.
Main Methods:
- Single-cell analysis
- Imaging-based spatial analysis
- Characterization of tumor-associated macrophages (TAMs)
- In vivo tumor models
Main Results:
- Identified three distinct microenvironmental neighborhoods in basal cell carcinoma.
- Discovered TREM2+ skin cancer-associated macrophages (SCAMs) supporting tumor epithelial proliferation via oncostatin-M/JAK-STAT3 signaling.
- Demonstrated that SCAMs are a unique, tumor-specific TREM2+ population expressing VCAM1, capable of self-propagation and rapid differentiation from monocytes.
Conclusions:
- SCAMs promote tumor proliferation through an immunosuppression-independent mechanism.
- SCAMs represent a novel, persistent immune cell population within the tumor microenvironment.
- These findings provide mechanistic insights into tumor-immune interactions and suggest potential combination therapy strategies.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Niche

